William Detten, DO
Family Medicine · Springfield, MONPI 1033229935
Payments from drug & device makers
Across 65 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$297
- Novo Nordisk$112
- Inspire Medical Systems, Inc.$100
- AbbVie$69
- Boehringer Ingelheim$68
- AstraZeneca$63
- plus $270 from 13 others
What the payments were for
- Food & beverage$980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $297 |
| Novo Nordisk | 7 | $112 |
| Inspire Medical Systems, Inc. | 1 | $100 |
| AbbVie(2 entities) | 4 | $69 |
| Boehringer Ingelheim | 5 | $68 |
| AstraZeneca | 5 | $63 |
| Daiichi Sankyo Inc. | 3 | $44 |
| GSK | 2 | $33 |
| Astellas Pharma US Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $27 |
| Abbott | 1 | $19 |
| Circassia Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Amgen | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$980 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $63,277 |
| MounjaroTirzepatide | 17 | $17,778 |
| Spiriva RespimatTiotropium Bromide | 26 | $14,571 |
| XareltoRivaroxaban | 19 | $13,047 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $7,291 |
| VascepaIcosapent Ethyl | 15 | $7,283 |
| JardianceEmpagliflozin | 11 | $6,837 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 22 | $6,322 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 18 | $5,493 |
| Arnuity ElliptaFluticasone Furoate | 15 | $3,498 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $2,537 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,166 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $2,072 |
| SynthroidLevothyroxine Sodium | 18 | $2,062 |
| Atorvastatin Calcium | 316 | $1,891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $297 | $68,77092 claims |
| Boehringer IngelheimSpiriva Respimat, Jardiance | $68 | $21,40937 claims |
| Lilly USA, LLCMounjaro | $27 | $17,77817 claims |
| GSKArexvy, Arnuity Ellipta | $33 | $9,82037 claims |
| AstraZenecaSymbicort | $63 | $7,29126 claims |
| AbbVieSynthroid | $69 | $2,06218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Springfield
- William HowittSpringfield$19.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Stephen AdamsSpringfield$636K
- Cory BethmannSpringfield$621K
- Roger CadySpringfield$175K
- Don BrockmanSpringfield$31K
- James van RiessenSpringfield$25K
- Timothy JenningsMaryland Heights$30.2M
- Rupal TrivediSaint Louis$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.